SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-16-016664
Filing Date
2016-09-09
Accepted
2016-09-09 17:13:24
Documents
70
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2016_relmadatherap.htm 10-K 1209707
2 AGREEMENT DATED, SEPTEMBER 98, 2016, BY AND BETWEEN SHREERAM AGHARKAR AND RELEMA f10k2016ex10xxv_relmada.htm EX-10.25 107054
3 LIST OF SUBSIDIARIES (INCORPORATED BY REFERENCE TO EXHIBIT 21.1 OF RELMADA'S FOR f10k2016ex21i_relmada.htm EX-21.1 1230
4 CERTIFICATION f10k2016ex31i_relmada.htm EX-31.1 10770
5 CERTIFICATION f10k2016ex31ii_relmada.htm EX-31.2 10679
6 CERTIFICATION f10k2016ex32i_relmada.htm EX-32.1 5686
7 CERTIFICATION f10k2016ex32ii_relmada.htm EX-32.2 5821
  Complete submission text file 0001213900-16-016664.txt   4757810

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE rlmd-20160630.xml EX-101.INS 713482
9 XBRL SCHEMA FILE rlmd-20160630.xsd EX-101.SCH 43265
10 XBRL CALCULATION FILE rlmd-20160630_cal.xml EX-101.CAL 40462
11 XBRL DEFINITION FILE rlmd-20160630_def.xml EX-101.DEF 189862
12 XBRL LABEL FILE rlmd-20160630_lab.xml EX-101.LAB 427453
13 XBRL PRESENTATION FILE rlmd-20160630_pre.xml EX-101.PRE 306227
Mailing Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016
Business Address 275 MADISON AVENUE, SUITE 702 NEW YORK NY 10016 646-677-3853
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55347 | Film No.: 161879450
SIC: 2834 Pharmaceutical Preparations